Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 11
1,170
Views
37
CrossRef citations to date
0
Altmetric
General Xenobiochemistry

A comprehensive assay for nine major cytochrome P450 enzymes activities with 16 probe reactions on human liver microsomes by a single LC/MS/MS run to support reliable in vitro inhibitory drug–drug interaction evaluation

, , , , , , , , & show all
Pages 961-977 | Received 12 Feb 2015, Accepted 30 Mar 2015, Published online: 26 May 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (9)

Ling Zhao, Fang Chen, Yuanli Zhang, Ling Yue, Hongrui Guo, Gang Ye, Fei Shi, Cheng Lv, Bo Jing, Huaqiao Tang, Zhongqiong Yin, Hualin Fu, Jvchun Lin, Yinglun Li & Xun Wang. (2020) Involvement of P450s and nuclear receptors in the hepatoprotective effect of quercetin on liver injury by bacterial lipopolysaccharide. Immunopharmacology and Immunotoxicology 42:3, pages 211-220.
Read now
Lu Liu, Xiangang Cao, Tingxin Li & Xiaohua Li. (2019) Effects of catalpol on the activity of human liver cytochrome P450 enzymes. Xenobiotica 49:11, pages 1289-1295.
Read now
Jingwei Zhang, Chuansheng Li, Jingfa Zhang & Fan Zhang. (2019) In vitro inhibitory effects of sophocarpine on human liver cytochrome P450 enzymes. Xenobiotica 49:10, pages 1127-1132.
Read now
Xin Wang, Zhou Qiao, Jia Liu, Mei Zheng, Wenyuan Liu & Chunyong Wu. (2018) Stereoselective in vitro metabolism of rhynchophylline and isorhynchophylline epimers of Uncaria rhynchophylla in rat liver microsomes. Xenobiotica 48:10, pages 990-998.
Read now
Gang Dong, Yun Zhou & Xiaoli Song. (2018) In vitro inhibitory effects of bergenin on human liver cytochrome P450 enzymes. Pharmaceutical Biology 56:1, pages 620-625.
Read now
Jinlan Wei, Hongying Zhang & Qingling Zhao. (2018) In vitro inhibitory effects of Friedelin on human liver cytochrome P450 enzymes. Pharmaceutical Biology 56:1, pages 363-367.
Read now
Jixiao Lang, Wei Li, Jingming Zhao, Kaiyou Wang & Dexi Chen. (2017) Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes. Xenobiotica 47:10, pages 849-855.
Read now
Hua-Qiao Tang, Min Xu, Qian Rong, Ru-Wen Jin, Qi-Ji Liu & Ying-Lun Li. (2016) The effect of ZnO nanoparticles on liver function in rats. International Journal of Nanomedicine 11, pages 4275-4285.
Read now

Articles from other publishers (28)

Diksha Manhas, Shipra Bhatt, Garima Rai, Vinay Kumar, Sahil Bharti, Sumit Dhiman, Shreyans K. Jain, Deepak K. Sharma, Probir Kumar Ojha, Sumit G. Gandhi, Anindya Goswami & Utpal Nandi. (2023) Rottlerin renders a selective and highly potent CYP2C8 inhibition to impede EET formation for implication in cancer therapy. Chemico-Biological Interactions 380, pages 110524.
Crossref
Yanzhou Tao, Yangyang Fan, Meizi Wang, Suqing Wang, Jing Jing Cui, Di Lian, Shuning Lu & Li Li. (2023) Comparative study of the interaction mechanism of astilbin, isoastilbin, and neoastilbin with CYP3A4. Luminescence.
Crossref
Marion Anliker‐Ort, Jasper Dingemanse, Stephane Delahaye, Luboš Janů, John van den Anker, Benjamin Berger & Priska Kaufmann. (2023) Evaluation of the cytochrome P450 2C19 and 3A4 inhibition potential of the complement factor 5a receptor 1 antagonist ACT ‐1014‐6470 in vitro and in vivo . Clinical and Translational Science 16:7, pages 1220-1231.
Crossref
Yujie Wu, Aiqing Qiao, Shu Lin & Lijia Chen. (2022) In vitro evaluation of the inhibition potential of echinacoside on human cytochrome P450 isozymes. BMC Complementary Medicine and Therapies 22:1.
Crossref
Abdulmohsen Alrohaimi, Bader Alrohaimi, Nada Alruwais & Kholoud Aldmasi. 2021. Pharmacogenetics. Pharmacogenetics.
Liang Wu, An Kang, Xiaoliang Jin, Yuqing Bao, Peng Miao, Tingmei Lv & Zhu Zhou. (2021) Ilexsaponin A1: In vitro metabolites identification and evaluation of inhibitory drug-drug interactions. Drug Metabolism and Pharmacokinetics 40, pages 100415.
Crossref
Ran Zhang, Dan Xu, Yirui Zhang, Rui Wang, Na Yang, Yunge Lou, Haokai Zhao, Jiye Aa, Guangji Wang & Yuan Xie. (2021) Silybin Restored CYP3A Expression through the Sirtuin 2/Nuclear Factor κ-B Pathway in Mouse Nonalcoholic Fatty Liver Disease. Drug Metabolism and Disposition 49:9, pages 770-779.
Crossref
Peter T. Doohan, Lachlan D. Oldfield, Jonathon C. Arnold & Lyndsey L. Anderson. (2021) Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization. The AAPS Journal 23:4.
Crossref
Helinä Kahma, Laura Aurinsalo, Mikko Neuvonen, Jani Katajamäki, Marie-Noëlle Paludetto, Jenni Viinamäki, Terhi Launiainen, Anne M. Filppula, Aleksi Tornio, Mikko Niemi & Janne T. Backman. (2021) An automated cocktail method for in vitro assessment of direct and time-dependent inhibition of nine major cytochrome P450 enzymes – application to establishing CYP2C8 inhibitor selectivity. European Journal of Pharmaceutical Sciences 162, pages 105810.
Crossref
Saraswathisreeram Pranush Kumar, Deeki Doma Sherpa, Amit Kumar Sahu, Tarang Jadav, Rakesh Kumar Tekade & Pinaki Sengupta. (2021) Innovation in bioanalytical strategies and in vitro drug–drug interaction study approaches in drug discovery . Bioanalysis 13:6, pages 513-532.
Crossref
Jasleen K. Sodhi & Jason S. Halladay. 2021. Enzyme Kinetics in Drug Metabolism. Enzyme Kinetics in Drug Metabolism 765 779 .
Eszter Fliszár-Nyúl, Violetta Mohos, Rita Csepregi, Přemysl Mladěnka & Miklós Poór. (2020) Inhibitory effects of polyphenols and their colonic metabolites on CYP2D6 enzyme using two different substrates. Biomedicine & Pharmacotherapy 131, pages 110732.
Crossref
Yu Fen Zheng, Soo Hyeon Bae, Zhouchi Huang, Soon Uk Chae, Seong Jun Jo, Hyung Joon Shim, Chae Bin Lee, Doyun Kim, Hunseung Yoo & Soo Kyung Bae. (2020) Lack of Correlation between In Vitro and In Vivo Studies on the Inhibitory Effects of (‒)-Sophoranone on CYP2C9 Is Attributable to Low Oral Absorption and Extensive Plasma Protein Binding of (‒)-Sophoranone. Pharmaceutics 12:4, pages 328.
Crossref
Jiali Liu, Xiaoliang Jin, Fang Zhou, Hongzhu Chen, Wenjie Wang, Yan Liu, Guangji Wang, Kun Hao & Jingwei Zhang. (2020) Disrupted hepatic pentose phosphate pathway directly participates in and indirectly promotes CYP3A reduction: A new strategy for CYP3A‐mediated drug hepatotoxicity. British Journal of Pharmacology 177:7, pages 1538-1555.
Crossref
Jia Hui Wang, Ke Qi Chen, Jun Xing Jiang, Huan Yong Li, Jun Ping Pan, Ji Yan Su, Lin Wang, Yang Hu, Xiang Nan Mi, Yi Rong Xin, Qin Gao, Xiang Long Zhao, Fei Xiao & Huan Min Luo. (2019) Excretion, Metabolism and Cytochrome P450 Inhibition of Methyl 3,4-Dihydroxybenzoate (MDHB): A Potential Candidate to Treat Neurodegenerative Diseases. European Journal of Drug Metabolism and Pharmacokinetics 45:1, pages 51-69.
Crossref
Huaqiao Tang, Min Xu, Jie Luo, Ling Zhao, Gang Ye, Fei Shi, Cheng Lv, Helin Chen, Yanyan Wang & Yinglun Li. (2019) Liver toxicity assessments in rats following sub-chronic oral exposure to copper nanoparticles. Environmental Sciences Europe 31:1.
Crossref
Sandhya Devarajan, Irene Moon, Ming-Fen Ho, Nicholas B. Larson, Drew R. Neavin, Ann M. Moyer, John L. Black, Suzette J. Bielinski, Steven E. Scherer, Liewei Wang, Richard M. Weinshilboum & Joel M. Reid. (2019) Pharmacogenomic Next-Generation DNA Sequencing: Lessons from the Identification and Functional Characterization of Variants of Unknown Significance in CYP2C9 and CYP2C19 . Drug Metabolism and Disposition 47:4, pages 425-435.
Crossref
Hyun‐Ji Kim, Hyunyoung Lee, Hyeon‐Kyeong Ji, Taeho Lee & Kwang‐Hyeon Liu. (2019) Screening of ten cytochrome P450 enzyme activities with 12 probe substrates in human liver microsomes using cocktail incubation and liquid chromatography–tandem mass spectrometry. Biopharmaceutics & Drug Disposition 40:3-4, pages 101-111.
Crossref
Daniel B Carrão, Anderson RM de Oliveira & Igor RS Magalhães. (2018) Challenges of probe cocktail approach for human drug–drug interaction assays. Bioanalysis 10:24, pages 1969-1972.
Crossref
Ang Chen, Xiaojing Zhou, Yi Cheng, Shuowen Tang, Mingyao Liu & Xin Wang. (2018) Design and optimization of the cocktail assay for rapid assessment of the activity of UGT enzymes in human and rat liver microsomes. Toxicology Letters 295, pages 379-389.
Crossref
Yannan Li, Jing Ning, Yan Wang, Chao Wang, Chengpeng Sun, Xiaokui Huo, Zhenlong Yu, Lei Feng, Baojing Zhang, Xiangge Tian & Xiaochi Ma. (2018) Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects. Toxicology Letters 294, pages 27-36.
Crossref
Huaqiao Tang, Min Xu, Fei Shi, Gang Ye, Cheng Lv, Jie Luo, Ling Zhao & Yinglun Li. (2018) Effects and Mechanism of Nano-Copper Exposure on Hepatic Cytochrome P450 Enzymes in Rats. International Journal of Molecular Sciences 19:7, pages 2140.
Crossref
Hyun-A Oh, Hyunbeom Lee, Donghak Kim & Byung Hwa Jung. (2017) Development of GC-MS based cytochrome P450 assay for the investigation of multi-herb interaction. Analytical Biochemistry 519, pages 71-83.
Crossref
Nicholas M. Njuguna, Ken-ichi Umehara, Felix Huth, Hilmar Schiller, Kelly Chibale & Gian Camenisch. (2016) Improvement of the chemical inhibition phenotyping assay by cross-reactivity correction. Drug Metabolism and Personalized Therapy 31:4, pages 221-228.
Crossref
Jing WANG, Hong WANG, Ying PENG, Guang-Ji WANG & Hai-Ping HAO. (2016) Isochlorogenic acid A affects P450 and UGT enzymes in vitro and in vivo. Chinese Journal of Natural Medicines 14:11, pages 865-870.
Crossref
Yuqing Cheng, Jing Zhou, Meiling Wang, Yanyan Liu, Bin Guo & Bo Chen. (2016) Single-shot multi-reaction monitoring of intact marker conjugates for quantitative profiling of human major microsomal glucuronidations and its utility to screen inhibitors from medicinal herbs. Analytical and Bioanalytical Chemistry 408:28, pages 8117-8132.
Crossref
Ang Chen, Xiaojing Zhou, Shuowen Tang, Mingyao Liu & Xin Wang. (2016) Evaluation of the inhibition potential of plumbagin against cytochrome P450 using LC-MS/MS and cocktail approach. Scientific Reports 6:1.
Crossref
Janne T. Backman, Anne M. Filppula, Mikko Niemi & Pertti J. Neuvonen. (2015) Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions. Pharmacological Reviews 68:1, pages 168-241.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.